Schedule 13G ownership disclosure

Raptor Pharmaceutical Corp

Security class unavailable · CUSIP: 75382F106

Event date: 2014-07-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,285,714
Percent of class
3.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950162-14-000042
Form type
SC 13G
Filer
HCRP OVERFLOW FUND, L.P./SERIES B
CIK
CIK 1609240
Filed
Jul 11, 2014
Reporting period
Jul 01, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub